CR8465A - Hormonas de administracion transdermica que no necesitan potenciadores de penetracion - Google Patents
Hormonas de administracion transdermica que no necesitan potenciadores de penetracionInfo
- Publication number
- CR8465A CR8465A CR8465A CR8465A CR8465A CR 8465 A CR8465 A CR 8465A CR 8465 A CR8465 A CR 8465A CR 8465 A CR8465 A CR 8465A CR 8465 A CR8465 A CR 8465A
- Authority
- CR
- Costa Rica
- Prior art keywords
- patch
- hormones
- potentiators
- transdermal administration
- need
- Prior art date
Links
- 229940088597 hormone Drugs 0.000 title abstract 3
- 239000005556 hormone Substances 0.000 title abstract 3
- 230000035515 penetration Effects 0.000 title abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 239000003623 enhancer Substances 0.000 abstract 2
- 230000036470 plasma concentration Effects 0.000 abstract 2
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 abstract 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 abstract 1
- 229940011871 estrogen Drugs 0.000 abstract 1
- 239000000262 estrogen Substances 0.000 abstract 1
- 229960002568 ethinylestradiol Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7076—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising ingredients of undetermined constitution or reaction products thereof, e.g. rosin or other plant resins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Dermatology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La invencion se refiere a un parche que comprende una capa de droga con un bajo contenido de hormonas, como por ejemplo gestodeno, y opcionalmente un estrogeno (por ejemplo etinilestradiol). Al aplicar el parche a una mujer, se consiguen niveles de plasma de al menos 1,0ng/ml de gestodeno en condiciones de estado estacionario sin necesidad de incorporar potenciadores de penetracion ni mejoradores de permeacion en la capa que contiene droga. Tambien son satisfactorios los niveles en plasma de las hormonas que se consiguen durante todo un periodo de al menos una semana, haciendo que el parche se pueda aplicar para utilizarlo en anticoncepcion femenina con el concepto de aplicar el parche una vez a la semana.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52871803P | 2003-12-12 | 2003-12-12 | |
| EP03078881 | 2003-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR8465A true CR8465A (es) | 2007-06-06 |
Family
ID=34924031
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR8465A CR8465A (es) | 2003-12-12 | 2006-06-20 | Hormonas de administracion transdermica que no necesitan potenciadores de penetracion |
Country Status (23)
| Country | Link |
|---|---|
| EP (2) | EP2138169B1 (es) |
| CN (1) | CN101843603B (es) |
| AR (1) | AR046762A1 (es) |
| AT (1) | ATE457168T1 (es) |
| CR (1) | CR8465A (es) |
| CY (2) | CY1110637T1 (es) |
| DE (1) | DE602004025444D1 (es) |
| DK (2) | DK2138169T3 (es) |
| ES (2) | ES2340925T3 (es) |
| GT (1) | GT200400262A (es) |
| HN (1) | HN2004000526A (es) |
| HR (2) | HRP20100254T1 (es) |
| JO (1) | JO2606B1 (es) |
| ME (1) | ME01069B (es) |
| MY (2) | MY144053A (es) |
| PE (1) | PE20051035A1 (es) |
| PL (2) | PL1541137T3 (es) |
| PT (2) | PT1541137E (es) |
| RS (2) | RS51260B (es) |
| SI (2) | SI1541137T1 (es) |
| SV (1) | SV2006001970A (es) |
| TW (1) | TWI257299B (es) |
| UA (1) | UA89766C2 (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SI1594483T1 (sl) | 2003-02-21 | 2006-12-31 | Schering Ag | UV-stabilni transdermalni terapevtski obliz |
| US8668925B2 (en) | 2003-12-12 | 2014-03-11 | Bayer Intellectual Property Gmbh | Transdermal delivery of hormones without the need of penetration enhancers |
| US8962013B2 (en) | 2005-05-02 | 2015-02-24 | Bayer Intellectual Property Gmbh | Multi-layered transdermal system with triazine UV absorber |
| DE102005050729A1 (de) * | 2005-10-19 | 2007-04-26 | Schering Ag | Verfahren zur präventiven bedarfsweisen hormonalen Kontrazeption |
| CA2740002C (en) | 2008-10-08 | 2016-11-01 | Agile Therapeutics, Inc. | Transdermal delivery |
| EP2343964A4 (en) | 2008-10-08 | 2012-11-07 | Agile Therapeutics Inc | TRANSDERMAL ADMINISTRATION |
| CA2740005C (en) | 2008-10-08 | 2016-11-01 | Agile Therapeutics, Inc. | Transdermal delivery |
| WO2010111488A1 (en) * | 2009-03-27 | 2010-09-30 | Agile Therapeutics, Inc. | Transdermal delivery |
| ES2617334T3 (es) | 2010-09-06 | 2017-06-16 | Bayer Intellectual Property Gmbh | Parches transdérmicos de dosificación baja con liberación elevada de fármaco |
| DE102010040299A1 (de) * | 2010-09-06 | 2012-03-08 | Bayer Schering Pharma Aktiengesellschaft | Transdermale therapeutische Systeme mit kristallisationsinhibierender Schutzfolie (Release Liner) |
| AU2015203180B2 (en) * | 2010-09-06 | 2016-06-30 | Bayer Intellectual Property Gmbh | Transdermal therapeutic systems with crystallization-inhibiting protective film (release liner) |
| HK1204287A1 (en) * | 2012-01-27 | 2015-11-13 | 敏捷治疗公司 | Transdermal hormone delivery |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4081537A (en) | 1975-10-10 | 1978-03-28 | Schering Aktiengesellschaft | Δ15 -Steroids and pharmaceutical compositions thereof |
| EP0394429B1 (de) * | 1988-10-27 | 1996-01-10 | Schering Aktiengesellschaft | Mittel zur transdermalen applikation enthaltend gestoden |
| US5512292A (en) | 1990-10-29 | 1996-04-30 | Alza Corporation | Transdermal contraceptive formulations methods and devices |
| MX9101787A (es) | 1990-10-29 | 1992-06-05 | Alza Corp | Formulaciones,metodos y dispositivos anticonceptivos transdermicos |
| DE4336557C2 (de) | 1993-05-06 | 1997-07-17 | Lohmann Therapie Syst Lts | Estradiolhaltiges transdermales therapeutisches System, Verfahren zu seiner Herstellung und seine Verwendung |
| DE4329242A1 (de) * | 1993-08-26 | 1995-03-02 | Schering Ag | Mittel zur transdermalen Applikation enthaltend Gestodenester |
| DE4405898A1 (de) * | 1994-02-18 | 1995-08-24 | Schering Ag | Transdermale therapeutische Systeme enthaltend Sexualsteroide |
| US5762956A (en) | 1996-04-24 | 1998-06-09 | Rutgers, The State University Of New Jersey | Transdermal contraceptive delivery system and process |
| DE19906152B4 (de) | 1999-02-10 | 2005-02-10 | Jenapharm Gmbh & Co. Kg | Wirkstoffhaltige Laminate für Transdermalsysteme |
| JP4841781B2 (ja) | 1999-11-24 | 2011-12-21 | アジル・セラピューティクス・インコーポレイテッド | 改良された経皮的避妊薬送達系および方法 |
| DE10053375C1 (de) * | 2000-10-27 | 2002-01-24 | Lohmann Therapie Syst Lts | Transdermale therapeutische Systeme mit lichtempfindlichen Wirkstoffen |
| TWI287455B (en) * | 2000-12-05 | 2007-10-01 | Noven Pharma | Crystallization inhibition of drugs in transdermal drug delivery systems and methods of use |
-
2004
- 2004-10-12 UA UAA200607580A patent/UA89766C2/ru unknown
- 2004-11-18 JO JO2004159A patent/JO2606B1/en active
- 2004-12-10 CN CN2010101564978A patent/CN101843603B/zh not_active Expired - Lifetime
- 2004-12-10 PL PL04078365T patent/PL1541137T3/pl unknown
- 2004-12-10 GT GT200400262A patent/GT200400262A/es unknown
- 2004-12-10 ES ES04078365T patent/ES2340925T3/es not_active Expired - Lifetime
- 2004-12-10 RS RSP-2010/0202A patent/RS51260B/sr unknown
- 2004-12-10 PL PL09173898T patent/PL2138169T3/pl unknown
- 2004-12-10 DK DK09173898.9T patent/DK2138169T3/da active
- 2004-12-10 AT AT04078365T patent/ATE457168T1/de active
- 2004-12-10 HN HN2004000526A patent/HN2004000526A/es unknown
- 2004-12-10 TW TW093138443A patent/TWI257299B/zh not_active IP Right Cessation
- 2004-12-10 EP EP09173898.9A patent/EP2138169B1/en not_active Expired - Lifetime
- 2004-12-10 RS YU20140050A patent/RS53182B/sr unknown
- 2004-12-10 EP EP04078365A patent/EP1541137B1/en not_active Expired - Lifetime
- 2004-12-10 DE DE602004025444T patent/DE602004025444D1/de not_active Expired - Lifetime
- 2004-12-10 SI SI200431404T patent/SI1541137T1/sl unknown
- 2004-12-10 ES ES09173898.9T patent/ES2445690T3/es not_active Expired - Lifetime
- 2004-12-10 PT PT04078365T patent/PT1541137E/pt unknown
- 2004-12-10 SI SI200432127T patent/SI2138169T1/sl unknown
- 2004-12-10 SV SV2004001970A patent/SV2006001970A/es not_active Application Discontinuation
- 2004-12-10 AR ARP040104605A patent/AR046762A1/es not_active Application Discontinuation
- 2004-12-10 PT PT91738989T patent/PT2138169E/pt unknown
- 2004-12-10 ME MEP-2010-79A patent/ME01069B/me unknown
- 2004-12-10 DK DK04078365.6T patent/DK1541137T3/da active
- 2004-12-10 MY MYPI20045107A patent/MY144053A/en unknown
- 2004-12-10 PE PE2004001230A patent/PE20051035A1/es active IP Right Grant
-
2006
- 2006-06-20 CR CR8465A patent/CR8465A/es unknown
-
2010
- 2010-03-31 MY MYPI2010001448 patent/MY152750A/en unknown
- 2010-05-04 HR HR20100254T patent/HRP20100254T1/hr unknown
- 2010-05-07 CY CY20101100401T patent/CY1110637T1/el unknown
-
2014
- 2014-01-24 HR HRP20140077TT patent/HRP20140077T1/hr unknown
- 2014-02-06 CY CY20141100099T patent/CY1115064T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20100143A7 (es) | Hormonas de administración transdérmica que no necesitan potenciadores de penetración | |
| CY1115064T1 (el) | Διαδερμικο συστημα παραδοσης ορμονων χωρις ενισχυτες διεισδυσης | |
| EE9900288A (et) | Peroraalselt manustatava farmatseutilise kompositsiooni kasutamine meeste erektiilse talitlushäire raviks ettenähtud ravimi valmistamiseks | |
| DK0836506T4 (da) | Transdermalt plaster til indgivelse af 17-deacetyl norgestimat alene eller i kombination med et østrogen | |
| NO20024586L (no) | FremgangsmÕte og preparat for prevensjon av hormoninduserte ugunstige virkninger | |
| MXPA04005211A (es) | Sistemas terapeuticos transdermicos que contienen hormona esteroides y monocaprilato de propilenglicol. | |
| CR7610A (es) | Uso de derivados de thio-oxindol en el tratamiento de condiciones realcionadas con la hormona | |
| DE602005026290D1 (de) | Zusammensetzungen mit verzögerter freisetzung mit progesteron-rezeptormodulatoren | |
| CR10732A (es) | Uso de valerato de estradiol o 17 b- estradiol en combinacion con dienogest en una terapia oral para mantener y / o incrementar la libido femenina | |
| PE20060467A1 (es) | Tratamiento de la hemorragia de disrupcion en regimenes anticonceptivos extendidos | |
| AR021459A1 (es) | PARCHE QUE CONTIENE ESTRADIOL PARA LA APLICACIoN PERCUTÁNEA DE HORMONAS. | |
| PE20040068A1 (es) | Decanoato, undecanoato y dodecanoato de etonogestrel | |
| CR10289A (es) | "estratrienos 9-alfa-sustituidos como estrogenos de eficacia selectiva"(divisional) | |
| UY28668A1 (es) | Hormonas de administración transdérmica que no necesitan potenciadores de penetración | |
| AR049197A1 (es) | Anticonceptivo hormonal conteniendo una combinacion de etinilestradiol y acetato de clormadinona | |
| CU23649B7 (es) | Hormonas de administración transdérmica que no necesitan potenciadores de penetración | |
| CR8059A (es) | Composicion farmaceutica en forma de hidrogel para administracion transdermica de sustancias activas | |
| PE20070119A1 (es) | Nuevos regimenes para dispositivos de suministro controlado de farmacos para la anticoncepcion | |
| DE69918124D1 (de) | Formulierungen zur transdermalen verabreichung von fenoldopam | |
| Lewis | Treatment of Erectile Dysfunction: Today and Tomorrow | |
| DOP2005000263A (es) | Emplasto transdermico con ligandos especificos de progesterona a (prasl) como principio activo. |